Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Progyny, Inc.PGNY · Entity 4521 | Director · Executive Chairman | January 02, 2026 | January 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Progyny, Inc.
Report date January 02, 2026 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 238,462 |
Reported balance
After 2026-01-02 transaction · row 1
1 source rowRow 1 · 2026-01-02 · Tax withholding · Disposed 2,171 · Balance 238,462 F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 01, 2021 Filed Nov 3, 2021 22:55 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 24,312 | $62.52 | $1,520,042.16 |
DisclosureSEC source: 0001179110-21-009865 · edgar.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,134 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8).The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8). F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.995 inclusive. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 22:55 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 22,554 | $61.83 | $1,394,466.46 |
DisclosureSEC source: 0001179110-21-009865 · edgar.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,446 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.49 to $61.995 inclusive. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8).The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8). Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 22:55 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 50,000 | $0.91 | $45,500.00 |
DisclosureSEC source: 0001179110-21-009865 · edgar.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 05, 2021 Filed Oct 5, 2021 23:28 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-009230 · edgar.xml · derivative · entry 11 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,534,384 Underlying: Common Stock · 50,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| October 05, 2021 Filed Oct 5, 2021 23:28 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 20,130 | $58.26 | $1,172,822.11 |
DisclosureSEC source: 0001179110-21-009230 · edgar.xml · nonDerivative · entry 8 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6) and (7). F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.00 to $58.77 inclusive. Read SEC document |
| October 05, 2021 Filed Oct 5, 2021 23:28 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 29,870 | $57.79 | $1,726,067.82 |
DisclosureSEC source: 0001179110-21-009230 · edgar.xml · nonDerivative · entry 7 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,130 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6) and (7). F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.40 to $57.995 inclusive. Read SEC document |
| October 05, 2021 Filed Oct 5, 2021 23:28 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 50,000 | $0.91 | $45,500.00 |
DisclosureSEC source: 0001179110-21-009230 · edgar.xml · nonDerivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 04, 2021 Filed Oct 5, 2021 23:28 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-009230 · edgar.xml · derivative · entry 10 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,584,384 Underlying: Common Stock · 50,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| October 04, 2021 Filed Oct 5, 2021 23:28 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 50,000 | $57.34 | $2,866,775.00 |
DisclosureSEC source: 0001179110-21-009230 · edgar.xml · nonDerivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6) and (7). F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.02 to $57.89 inclusive. Read SEC document |
| October 04, 2021 Filed Oct 5, 2021 23:28 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 50,000 | $0.91 | $45,500.00 |
DisclosureSEC source: 0001179110-21-009230 · edgar.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 23:28 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-009230 · edgar.xml · derivative · entry 9 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,634,384 Underlying: Common Stock · 50,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 23:28 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 36,310 | $57.42 | $2,085,007.34 |
DisclosureSEC source: 0001179110-21-009230 · edgar.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6) and (7). F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.01 to $57.91 inclusive. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 23:28 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 13,690 | $56.84 | $778,071.15 |
DisclosureSEC source: 0001179110-21-009230 · edgar.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,310 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.640 to $56.990 inclusive. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6) and (7). Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 23:28 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 50,000 | $0.91 | $45,500.00 |
DisclosureSEC source: 0001179110-21-009230 · edgar.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2021 Filed Sep 7, 2021 21:19 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-008656 · edgar.xml · derivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,684,384 Underlying: Common Stock · 50,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| September 03, 2021 Filed Sep 7, 2021 21:19 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 33,948 | $57.48 | $1,951,331.04 |
DisclosureSEC source: 0001179110-21-008656 · edgar.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4) and (5). F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.00 to $57.85 inclusive. Read SEC document |
| September 03, 2021 Filed Sep 7, 2021 21:19 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 15,152 | $56.58 | $857,300.16 |
DisclosureSEC source: 0001179110-21-008656 · edgar.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,948 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4) and (5). F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.00 to $56.99 inclusive. Read SEC document |
| September 03, 2021 Filed Sep 7, 2021 21:19 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 900 | $55.63 | $50,067.00 |
DisclosureSEC source: 0001179110-21-008656 · edgar.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,100 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.53 to $55.70 inclusive. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4) and (5). Read SEC document |
| September 03, 2021 Filed Sep 7, 2021 21:19 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 50,000 | $0.91 | $45,500.00 |
DisclosureSEC source: 0001179110-21-008656 · edgar.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 20:42 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-008593 · edgar.xml · derivative · entry 8 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,734,384 Underlying: Common Stock · 50,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 20:42 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 36,200 | $56.37 | $2,040,594.00 |
DisclosureSEC source: 0001179110-21-008593 · edgar.xml · nonDerivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5) and (6). F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.00 to $56.84 inclusive. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 20:42 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 13,800 | $56.00 | $772,800.00 |
DisclosureSEC source: 0001179110-21-008593 · edgar.xml · nonDerivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,200 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5) and (6). F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.45 to $55.995 inclusive. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 20:42 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 50,000 | $0.91 | $45,500.00 |
DisclosureSEC source: 0001179110-21-008593 · edgar.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 20:42 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-008593 · edgar.xml · derivative · entry 7 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,784,384 Underlying: Common Stock · 50,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 20:42 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 31,578 | $56.32 | $1,778,472.96 |
DisclosureSEC source: 0001179110-21-008593 · edgar.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5) and (6). F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.00 to $56.64 inclusive. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 20:42 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 18,422 | $55.72 | $1,026,473.84 |
DisclosureSEC source: 0001179110-21-008593 · edgar.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,578 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.25 to $55.99 inclusive. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5) and (6). Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 20:42 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 50,000 | $0.91 | $45,500.00 |
DisclosureSEC source: 0001179110-21-008593 · edgar.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 26, 2021 Filed Aug 27, 2021 22:32 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 34,691 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-008464 · edgar.xml · derivative · entry 7 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,834,384 Underlying: Common Stock · 34,691 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| August 26, 2021 Filed Aug 27, 2021 22:32 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 34,691 | $51.61 | $1,790,402.51 |
DisclosureSEC source: 0001179110-21-008464 · edgar.xml · nonDerivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4) and (5). F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.47 to $51.89 inclusive. Read SEC document |
| August 26, 2021 Filed Aug 27, 2021 22:32 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 34,691 | $0.91 | $31,568.81 |
DisclosureSEC source: 0001179110-21-008464 · edgar.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,691 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 25, 2021 Filed Aug 27, 2021 22:32 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 115,309 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-008464 · edgar.xml · derivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,869,075 Underlying: Common Stock · 115,309 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| August 25, 2021 Filed Aug 27, 2021 22:32 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 8,501 | $52.20 | $443,752.20 |
DisclosureSEC source: 0001179110-21-008464 · edgar.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4) and (5). F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.015 to $52.62 inclusive. Read SEC document |
| August 25, 2021 Filed Aug 27, 2021 22:32 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 106,808 | $51.70 | $5,521,973.60 |
DisclosureSEC source: 0001179110-21-008464 · edgar.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,501 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.62 to $51.995 inclusive. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4) and (5). Read SEC document |
| August 25, 2021 Filed Aug 27, 2021 22:32 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 115,309 | $0.91 | $104,931.19 |
DisclosureSEC source: 0001179110-21-008464 · edgar.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 25, 2021 Filed Jun 28, 2021 22:09 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 6,894 | $60.00 | $413,640.00 |
DisclosureSEC source: 0001179110-21-007086 · edgar.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.96 to $60.04 inclusive. F3 · ownership.nature: The reportable securities are held directly by DS2019 LLC (the "DS LLC"), which is owned by David Schlanger 2019 Grantor Retained Annuity Trust (the "DS GRAT"). The Reporting Person is the managing member of the DS LLC, and the Reporting Person's spouse is the trustee of the DS GRAT. Read SEC document |
| June 25, 2021 Filed Jun 28, 2021 22:09 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 107,121 | $59.41 | $6,364,058.61 |
DisclosureSEC source: 0001179110-21-007086 · edgar.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,894 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.96 to $59.95 inclusive. F3 · ownership.nature: The reportable securities are held directly by DS2019 LLC (the "DS LLC"), which is owned by David Schlanger 2019 Grantor Retained Annuity Trust (the "DS GRAT"). The Reporting Person is the managing member of the DS LLC, and the Reporting Person's spouse is the trustee of the DS GRAT. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 22:09 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 105,987 | $59.46 | $6,301,987.02 |
DisclosureSEC source: 0001179110-21-007086 · edgar.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 114,015 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.25 to $59.67 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4) and (5). Read SEC document |
| June 03, 2021 Filed Jun 8, 2021 01:58 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-006471 · edgar.xml · derivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,984,384 Underlying: Common Stock · 50,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| June 03, 2021 Filed Jun 8, 2021 01:58 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 4,140 | $63.13 | $261,358.20 |
DisclosureSEC source: 0001179110-21-006471 · edgar.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.00 to $63.30 inclusive. Read SEC document |
| June 03, 2021 Filed Jun 8, 2021 01:58 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 41,360 | $62.50 | $2,585,000.00 |
DisclosureSEC source: 0001179110-21-006471 · edgar.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,140 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.9950 inclusive. Read SEC document |
| June 03, 2021 Filed Jun 8, 2021 01:58 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 4,500 | $61.90 | $278,550.00 |
DisclosureSEC source: 0001179110-21-006471 · edgar.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,500 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.63 to $61.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4). Read SEC document |
| June 03, 2021 Filed Jun 8, 2021 01:58 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 50,000 | $0.91 | $45,500.00 |
DisclosureSEC source: 0001179110-21-006471 · edgar.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 01:23 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-006399 · edgar.xml · derivative · entry 11 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,034,384 Underlying: Common Stock · 50,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 01:23 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 6,000 | $65.26 | $391,558.20 |
DisclosureSEC source: 0001179110-21-006399 · edgar.xml · nonDerivative · entry 8 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.65 inclusive. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 01:23 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 8,052 | $64.66 | $520,666.48 |
DisclosureSEC source: 0001179110-21-006399 · edgar.xml · nonDerivative · entry 7 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.00 to $64.9950 inclusive. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 01:23 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 20,748 | $63.56 | $1,318,705.53 |
DisclosureSEC source: 0001179110-21-006399 · edgar.xml · nonDerivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,052 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.00 to $63.99 inclusive. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 01:23 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 15,200 | $62.77 | $954,053.84 |
DisclosureSEC source: 0001179110-21-006399 · edgar.xml · nonDerivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,800 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.34 to $62.99 inclusive. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 01:23 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 50,000 | $0.91 | $45,500.00 |
DisclosureSEC source: 0001179110-21-006399 · edgar.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 4, 2021 01:23 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-006399 · edgar.xml · derivative · entry 10 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,084,384 Underlying: Common Stock · 50,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| June 01, 2021 Filed Jun 4, 2021 01:23 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 23,496 | $64.24 | $1,509,307.85 |
DisclosureSEC source: 0001179110-21-006399 · edgar.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.00 to $64.76 inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.